Novel nucleic acid molecules and polypeptides encoding baboon TAFI
AssigneeBristol-Myers Squibb Company
InventorsJames K. Tamura, Gary R. Matsueda, Mei-Yin Hsu, Akbar Nayeem
Life of this patent
Estimating the term…
Loading patent…
AssigneeBristol-Myers Squibb Company
InventorsJames K. Tamura, Gary R. Matsueda, Mei-Yin Hsu, Akbar Nayeem
Estimating the term…
The present invention relates to the isolation and identification of novel baboon nucleic acid molecules and proteins and polypeptides encoded by such nucleic acid molecules, or degenerate variants thereof, which proteins and polypeptides comprise novel baboon thrombin-activatable fibrinolysis inhibitors or “TAFI” enzyme molecules. Because the novel baboon TAFI proteins and polypeptides of the invention inhibit the breakdown of blood clots, they may be therapeutically useful for the treatment of blood disorders wherein clotting needs to be regulated or promoted, such as hemophilia or von Willebrand's disease or in other situations, such as trauma, wherein blood clotting or coagulation needs to be regulated or promoted. The sequences of the invention are also useful in screening methods for the identification of compounds that modulate the expression of the baboon TAFI nucleic acids and/or the activity of the baboon TAFI proteins and polypeptides of the invention. Such agonist or antagonist compounds may be useful in the treatment of various blood clotting disorders and conditions requiring hemostatic control such as hemophilia or various thrombotic diseases such as deep venous thrombosis, coronary artery disease, stroke associated with atrial fibrillation and recurrent thrombosis following stroke or myocardial infarction.
An isolated nucleic acid molecule comprising a polynucleotide having a nucleotide sequence selected from the group consisting of:
An isolated polypeptide comprising an amino acid sequence selected from the group consisting of:
An isolated nucleic acid molecule consisting of a polynucleotide having a nucleotide sequence selected from the group consisting of:
An isolated polypeptide consisting of an amino acid sequence selected from the group consisting of:
A computer for producing a three-dimensional representation of a molecule or molecular complex, wherein said molecule or molecular complex comprises the structural coordinates of baboon TAFI provided in accordance with Table I, wherein said computer comprises:
A method for identifying a mutant with altered biological properties, function, or activity of baboon TAFI, wherein said method comprises the steps of:
A method for designing or selecting compounds as potential modulators of baboon TAFI, wherein said method comprises the steps of:
A computer for producing a three-dimensional representation of a molecule or molecular complex, wherein said molecule or molecular complex comprises the structural coordinates of human TAFI provided in accordance with Table II, wherein said computer comprises:
A method for identifying a mutant with altered biological properties, function, or activity of human TAFI, wherein said method comprises the steps of:
A method for designing or selecting compounds as potential modulators of human TAFI, wherein said method comprises the steps of:
rationally designing compounds that bind to said feature.
Dependencies are inferred from the claim text.